Insider buying last 90 days
No open-market insider purchases were filed for MANH in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Manhattan Associates reported Q3 2026 results with $306.19 million in revenue and $61.34 million in net income, alongside new full-year 2026 guidance, with commentary framing a 10% fair value gap following the print. Argus raised its target price for MANH to $259.00 as of October 28, 2026, while the company also marked the occasion by ringing the Nasdaq Closing Bell. A director filing disclosed that Linda T. Hollembaek sold 1,315 shares on November 3 at $250 per share; separately, a law firm announced an investigation into the company's officers and directors.
The stock closed at $251.72, down 0.4%, sitting above both its 50-day ($221.08) and 200-day ($168.86) moving averages, with one-month, three-month, six-month and one-year returns of 22.9%, 29%, 82.8% and 43.4% respectively. The GekkoIndex reads 47.4, placing MANH in the Neutral zone, up 7.2 over the past five readings. Price stands 23.3% above Gekko Fair Value of $204.12.
The next earnings date falls on 26 January 2027, 77 days out and beyond a typical 20-trading-day hold. No insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows. Seasonally, the next 20 trading days have averaged a 1.2% return over 5 years, rising in 3 of them. Analyst consensus across 8 firms shows 7 buy and 1 hold ratings, with a consensus target of $275 implying 9.2% upside.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Manhattan Associates scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
Above 50 and 200-day
Close $257.15 is above the 50-day ($224.11) and 200-day ($170.69) averages, and the 50-day is above the 200-day.
See the chart50.1, Neutral
Reading 50.1 is in the Neutral zone.
See the GekkoIndex24.3% above
Price is 24.3% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 72 days
Next report Jan 26, 2027, 72 days away — outside a typical 20-trading-day hold.
See earnings−2.0% on average
From this point in the calendar, the next 20 trading days averaged −2% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Manhattan Associates closed at $257.15 on Nov 13, 2026, +46.7% over the past year, inside a 52-week range of $119.06 to $263.47.
Use the left and right arrow keys to read daily values.
Put MANH on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Manhattan Associates builds software that helps businesses run their supply chains, track inventory, and coordinate sales across multiple channels. Its lineup includes Manhattan SCALE, a set of tools for warehouse management, transportation execution, yard operations, and trading partner coordination, along with Manhattan Active, which ties together enterprise and in-store omni-channel functions. The company also produces tools focused specifically on inventory planning, optimization, and allocation.
Beyond its software, the company provides maintenance, implementation consulting, training, and change management to support customers using its systems, and it resells related hardware like RF terminals, RFID readers, and barcode scanners. It reaches customers through its own sales force as well as through partner arrangements, working with organizations in grocery, food and beverage, manufacturing, pharmaceuticals, retail, wholesale, and third-party logistics. Its customer base extends across the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Manhattan Associates was founded in 1990 and is headquartered in Atlanta, Georgia. Its shares are listed on the NASDAQ under the ticker MANH.
Manhattan Associates’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.1, in the Neutral zone, up 3.5 points over five sessions.
Up 3.5 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 43 | −1.1% | −1.6% | ||
| Accumulation | 228 | +0.4% | −1.2% | ||
| Neutral (current zone) | 379 | +0.4% | +1.8% | ||
| Distribution | 47 | +0.2% | +3.2% | ||
| Selling | 5 | Too few readings yet | |||
Average MANH share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Manhattan Associates trades 24.3% above Gekko Fair Value of $206.91, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Manhattan Associates shares are worth, recalculated every trading day.
$206.91
Gekko Fair Value, Nov 14, 2026
24.3% Overvalued
At the end of Aug 2026 the price was 40.7% above the estimate.
No open-market insider purchases were filed for Manhattan Associates, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MANH in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MANH were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Manhattan Associates has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds MANH.
Manhattan Associates reports on Jan 26, 2027, after the close (72 days away), and beat the EPS estimate in 8 of its last 8 reports.
Jan 26, 2027
Expected after the close, 72 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 28, 2026 | $1.39 est $1.32 | $297.8M est $289.0M | +28.1% |
| Apr 21, 2026 | $1.24 est $1.23 | $282.2M est $273.7M | +6.8% |
| Jan 27, 2026 | $1.21 est $1.13 | $270.4M est $264.7M | −9.1% |
| Oct 21, 2025 | $1.36 est $1.19 | $275.8M est $271.8M | −2.7% |
| Jul 22, 2025 | $1.31 est $1.13 | $272.4M est $263.7M | +9.0% |
| Apr 22, 2025 | $1.19 est $1.03 | $262.8M est $256.5M | +7.1% |
| Jan 28, 2025 | $1.17 est $1.06 | $255.8M est $253.1M | −22.7% |
| Oct 22, 2024 | $1.35 est $1.06 | $266.7M est $262.9M | −8.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Manhattan Associates is $276.00, +7.3% from the last close, from 8 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 8 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | Stifel Nicolaus | $300 | +16.7% |
| Nov 2 | Barclays | $275 | +6.9% |
| Oct 28 | Truist Financial | $305 | +18.6% |
| Oct 28 | Robert W. Baird | $290 | +12.8% |
| Oct 28 | Stifel Nicolaus | $300 | +16.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Manhattan Associates averaged −2.0% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −3.2% | 1 of 5 |
| Next 10 trading days | −2.6% | 2 of 5 |
| Next 15 trading days | −2.1% | 2 of 5 |
| Next 20 trading days | −2.0% | 2 of 5 |
| Next 30 trading days | −4.3% | 0 of 5 |
For scale, MANH’s typical 20-trading-day move in either direction is about 6.4%.
Manhattan Associates’s market cap is $14.93B, with a P/E ratio of 71.8 and revenue of $1.16B over the last twelve months.
Coverage of Manhattan Associates this week reads positive: 3 positive, 3 neutral and 0 negative headlines.
Manhattan Associates’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 10.6% above |
| PLTRPalantir Technologies | Accumulation | 8.2% below |
| ORCLOracle | Neutral | 27.9% below |
| PANWPalo Alto Networks | Accumulation | 0.6% above |
| CRWDCrowdStrike | Accumulation | 0.9% above |
| CRMSalesforce | Accumulation | 12.1% below |
A peer links to its own page where one exists.
Manhattan Associates’s market cap is $14.93B at the Nov 13, 2026 close of $257.15, with 58.06M shares outstanding. The shares trade on a P/E ratio of 71.8.
The consensus analyst 12-month price target for Manhattan Associates is $276.00, +7.3% from the last close. Of the 8 firms that rated the stock in the last 90 days, 7 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Manhattan Associates is overvalued: the Nov 13, 2026 close of $257.15 is 24.3% above Gekko Fair Value of $206.91. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Manhattan Associates is expected to report on Jan 26, 2027, after the market closes (72 days away). Analysts expect earnings of $1.39 per share on revenue of $291.5M. Manhattan Associates beat the earnings estimate in 8 of its last 8 reports, moving 11.7% on average across the report.
Manhattan Associates’s 52-week high is $263.47 and its 52-week low is $119.06; it closed at $257.15 on Nov 13, 2026, +46.7% over the past year. Over the last five years the shares peaked at $312.60 on Dec 12, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and earnings risk), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.